Related Experiment Video
Updated: Aug 17, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology
Peter J Helms1, Suzie Ekins Daukes, Michael W Taylor
1Department of Child Health, School of Medicine, University of Aberdeen, UK. p.j.helms@abdn.ac.uk
Insights
Off-label prescribing in children is common in primary care, often due to incorrect dosages or age recommendations. Unlicensed medicines were not found, but off-label use is prevalent, particularly in younger and older pediatric patients.
Area of Science:
- Pediatric pharmacology
- Primary care medicine
- Medication safety
Background:
- Pediatric medication prescribing predominantly occurs in primary care for common conditions.
- Secondary care involves fewer children but a wider range of complex medications for serious illnesses.
Purpose of the Study:
- To investigate unlicensed and off-label prescribing patterns in children within a primary care setting.
- To compare prescribing data with general practice consultation data for a common pediatric condition.
Main Methods:
- Analysis of prescribing data from the General Practice Administration System for Scotland (GPASS) (Nov 1999-Oct 2000).
- Examination of off-label prescribing in children aged 0-16 years.
- Comparison of age-specific asthma consultations using GPASS and the General Practice Research Database (GPRD).
Main Results:
- No instances of unlicensed prescribing were identified among the 214 medicines studied.
- Off-label prescribing was most frequent in younger and older children.
- Common reasons for off-label prescriptions included incorrect dosage (lower/higher) and prescribing outside the recommended age range.
Conclusions:
- Large primary care datasets within unified healthcare systems (e.g., NHS) are compatible and yield reliable results.
- Off-label medication prescribing for children is common in primary care, primarily due to deviations from recommended dosage regimens.
Background:
The majority of medicines prescribed for children are prescribed in primary care for common acute and chronic conditions. This is in contrast to prescribing in secondary care where the population of children admitted is small but where a large number of different medicines are prescribed to treat more serious and less common conditions.
Methods:
Data on prescribing was extracted from the General Practice Administration System for Scotland (GPASS) for the year November 1999 to October 2000 and prescribing patterns for children aged 0-16 years expressed as percentages. A comparison of age specific consultations for asthma, as an example of a common paediatric condition, was also made between two separate general practice data sets, the General Practice Research Database (GRPD) and the continuous morbidity recording (CMR) subset of GPASS.
Results:
Of 214 medicines investigated for unlicensed and off-label prescribing no unlicensed prescribing was identified. Off-label prescribing due to age was most common among younger and older children. The most common reasons for off-label prescriptions were, in order of frequency, lower than recommended dose, higher than recommended dose, below the recommended age, and unlicensed formulation. Age and gender specific consultations for asthma were similar in the two representative databases, GPRD and CMR, both showing disappearance of the male predominance in the teenage years.
Conclusions:
Large primary care data sets available within a unified health care system such as the UK National Health Service (NHS) are likely to be broadly compatible and produce similar results. The prescribing of off-label medicines to children is common in primary care, most commonly due to prescribing out with the recommended dosage regimen.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution